1-4 of 4
Mark A. Cook
Close
Sort by
Journal Articles

Redefining nonmeasurable multiple myeloma using mass spectrometry

Clinical Trials & Observations
Hannah V. Giles, Mark A. Cook, Mark Trehane Drayson, Gordon Cook, Nicola Jane Wright, Simon John North, Stephen Harding, David A. Cairns, Anna Hockaday, Martin F. Kaiser, Paul Moss, Faith E. Davies, Gareth J. Morgan, Graham Jackson, Guy Pratt
Journal: Blood
Blood (2022) 139 (6): 946–950.
https://doi.org/10.1182/blood.2021013794
Published: 2022
Includes: Supplemental data
Journal Articles

How I treat monoclonal gammopathy of renal significance (MGRS)

Jean-Paul Fermand, Frank Bridoux, Robert A. Kyle, Efstathios Kastritis, Brendan M. Weiss, Mark A. Cook, Mark T. Drayson, Angela Dispenzieri, Nelson Leung
Journal: Blood
Blood (2013) 122 (22): 3583–3590.
https://doi.org/10.1182/blood-2013-05-495929
Published: 2013
Journal Articles

Donor KIR Genotype Does Not Affect VZV Reactivation after Allogeneic Haematopoietic Stem Cell Transplantation.

Sujaatha Narayanan, MBBS, Sandeep Nagra, MBChB, Premini Mahendra, MD, FRCPath, Fiona J. Clark, MRCPath, Charles F. Craddock, PhD, FRCPath, Husam Osman, PhD, MRCPath, David C. Briggs, PhD, Paul A. Moss, PhD, FRCPath, Mark A. Cook, MRCPath
Journal: Blood
Blood (2005) 106 (11): 3236.
https://doi.org/10.1182/blood.V106.11.3236.3236
Published: 2005
Journal Articles

The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia

Mark A. Cook, Donald W. Milligan, Christopher D. Fegan, Philip J. Darbyshire, Premini Mahendra, Charles F. Craddock, Paul A. H. Moss, David C. Briggs
Journal: Blood
Blood (2004) 103 (4): 1521–1526.
https://doi.org/10.1182/blood-2003-02-0438
Published: 2004